Luzu is a topical antifungal medication that contains the active ingredient luliconazole. It belongs to the azole class of antifungal agents and is formulated as a 30 g tube for external use on the skin. In Hong Kong, Luzu is regulated as a prescription-only product under the Pharmacy and Poisons Ordinance, and it is intended for the treatment of various superficial fungal infections.
Luliconazole belongs to the imidazole subclass of azole antifungals. It works by inhibiting the enzyme lanosterol 14α-demethylase, which is essential for the synthesis of ergosterol, a key component of fungal cell membranes. Without ergosterol, the fungal cell membrane becomes unstable, leading to leakage of cellular contents and ultimately fungal cell death.
Key pharmacologic features:
Luzu is approved in Hong Kong for the topical treatment of:
These indications align with the typical uses of luliconazole as an antifungal agent for superficial skin infections.
These reactions are usually transient and resolve with continued use or after cessation of therapy.
Luliconazole is applied topically and has minimal systemic absorption, so clinically significant drug-drug interactions are rare. Nevertheless:
Note: Dosing must be individualized by a qualified healthcare provider based on infection severity, site, and patient factors.
Routine laboratory monitoring is not required for topical luliconazole. However:
This article provides educational information about Luzu and is not a substitute for professional medical advice. Treatment decisions, including the use of unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Luzu is formulated for use on the skin and nails; it is not designed for scalp application. For scalp dermatophyte infections, a shampoo or lotion specifically approved for that area should be considered.
Most patients notice reduced itching and redness within 3-5 days of consistent daily application. Complete clearance of the infection may require 2-4 weeks, depending on the condition treated.
Luzu is not routinely recommended for children younger than 12 years unless a pediatric specialist prescribes it and monitors therapy closely.
Yes, a gentle, fragrance-free moisturizer can be applied after Luzu has been absorbed (usually 15-30 minutes). Avoid layering another topical medication simultaneously unless directed by a clinician.
A mild rash may represent irritation; stop using Luzu and rinse the area with water. If the rash persists, spreads, or is accompanied by swelling, seek medical attention promptly.
Since Luzu has minimal systemic absorption, significant interactions with oral antifungals are unlikely. However, inform your prescriber about all topical and oral medications you are using.
Coverage depends on the specific public or private health plan. Patients should verify reimbursement details with their insurer or the Hospital Authority.
Yes, Luzu in its original packaging is allowed in carry-on luggage. Keep the tube sealed and declare it if asked by security personnel.
Luzu contains luliconazole, which has a broader spectrum and a lower minimum inhibitory concentration compared with many OTC azoles like clotrimazole. Prescription status also ensures professional oversight of its use.
Place the empty tube in household waste if local regulations permit, or follow the Hong Kong Department of Health’s guidelines for pharmaceutical waste by delivering it to a designated collection point.
